Ocugen (OCGN) announced it had finalized its deal with India-based Bharat Biotech top commercialize COVAXIN COVID-19 vaccine already in use in India
J&J said its EUA will be based on topline efficacy and safety data from the nearly 44,000-patient Phase III ENSEMBLE trial
Johnson & Johnson’s Janssen unit has filed its single dose COVID-19 vaccine candidate with the FDA, asking for The post J&J asks FDA for emergency clearance...
Gilead’s COVID-19 drug Veklury (remdesivir) is helping the company through disruption caused by the pandemic and patent expiry The post Veklury rescues Gilead from COVID doldrums...
Today we will know the important employment data of the United States, with the publication of the NFP and the unemployment rate from last month
Futures Hit All Time High, Oil Soars Ahead Of Jobs Report With overnight US equity futures rising for a 5th straight day, tracking global markets, the...
NAIOP conducted its seventh survey of its U.S. members on the impacts of COVID-19. Since April, the association has examined the pandemic’s effects on commercial real...
Speaking with GEN last month, a Jazz executive said the company is moving toward expanding in neuroscience beyond sleep indications, through a mix of multiple indications...
The lack of face-to-face meetings during the Covid-19 pandemic caused the U.S. Food and Drug Administration to implement regulatory workarounds to stay on top of drug...
New research findings correlate with clinical observations of more fetal abnormalities and other Zika-related health problems in late versus early pregnancy Credit: Photo courtesy of USF...
Loss of muscle mass is a growing concern for the tens of millions of older Americans. It leads to falls and increased isolation, already a huge...
Stirred to action by the COVID-19 pandemic, vaccine stalwarts mobilize new formats, accelerate development, and scale up manufacturing. The post The Sleeping Giants of Vaccine Production...
Overview The bull case for Esperion Therapeutics (ESPR) neatly falls into three categories. There is a lot to like here, however, the recent missteps need to...
Moderna is proposing filling vials with additional doses of the COVID-19 vaccine to increase supply as the company approaches the manufacturing of almost a million doses...
Adamas Pharmaceuticals’ Parkinson’s drug Gocovri has a new indication as an adjunctive treatment for levodopa/carbodopa in patients with The post Competition for Neurocrine as Gocovri picks...
Bristol-Myers Squibb’s commercial hopes for new multiple sclerosis drug Zeposia have yet to bear fruit thanks to the The post BMS eyes May FDA verdict for...
Shares of Viela Bio skyrocketed more than 52% in trading after Ireland’s Horizon Therapeutics announced the acquisition of the rare disease medicines company in a $3.05 billion...
Ludwig von Mises’s 1944 book Bureaucracy is an investigation into the dramatic expansion of bureaucratic management in the United States.1 Bureaucracy mushroomed in accordance with Woodrow...
COVID Lockdowns Spark Biggest Cigarette Sales Spike In Years During the first months of quarantine, when nobody really had any idea whether they'd be seeing their...
Multipronged BU research team finds 18 FDA-approved drugs that could halt coronavirus infection earlier Credit: Courtesy of Hekman, et al. What if scientists knew exactly what...
The EMA has approved AstraZeneca’s COVID-19 vaccine for use in the EU in all adults aged over 18
Johnson & Johnson Shares Tumble After Reporting Vaccine Effectiveness from results of its Phase 3 COVID-19 vaccine trials, and they are disappointing.
NVX-CoV2373 achieved 60% efficacy in a Phase IIb trial in South Africa, where that country’s escape variant of the virus (B.1.351, also known as 20H/501Y.V2) was...
Shares of Novavax spiked almost 27% in Thursday’s extended market session after the biotech company announced that its coronavirus vaccine showed to be 89.3% effective against...
First Cases Of South African COVID Mutant Discovered In The US: Live Updates Summary: South African variant arrives in US NYC vaccine logjam eases AstraZeneca battle...
EU Spat With AstraZeneca Continues As Russia Offers Help With COVID Vaccines
It has been five years since the first biosimilar launched in United States market—marking the first steps in The post The US biosimilar market: Predictions for...
FDA Issues "Import Alert" On Potentially Deadly Mexican Hand Sanitizer The US Food and Drug Administration (FDA) issued a rare "import alert" Tuesday on alcohol-based hand sanitizers originating from...
Much of the attention on Pfizer, BioNTech, Moderna, Johnson & Johnson and AstraZeneca has been on their Covid-19 vaccine efforts, and here is a look at what else...
Eli Lilly said new data showed that treatment with 2 of its antibody therapies lowered COVID-19-related hospitalizations & deaths in high-risk patients by 70%.